By Professor David Goldstein

Conference Papers

Pothula S; Xu Z; Goldstein D; Pirola R; Wilson J; Apte M, 2017, 'Stromal reprogramming offers a novel therapeutic approach in pancreatic cancer: Implications of targeting HGF/c-MET pathway', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 62 - 62, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bekaii-Saab T; Goldstein D; Li CP; Okusaka T; O'Neil B; Reni M; Tabernero J; Qin S; Van Cutsem E; Borodyansky L; Li CJ, 2017, 'CanStem111P trial: A phase III study of napabucasin plus nab-paclitaxel (nab-PTX) with gemcitabine (gem) in adult patients with metastatic pancreatic adenocarcinoma (mPDAC)', in Annals of Oncology, pp. iii136, http://dx.doi.org/10.1093/annonc/mdx261.379

Clifford B; Barry B; Simar D; Goldstein D, 2017, 'Exercise Induced Analgesia in Survivors of Cancer', in MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, LIPPINCOTT WILLIAMS & WILKINS, CO, Denver, pp. 163 - 163, presented at Annual Meeting of the American-College-of-Sports-Medicine (ACSM), CO, Denver, 30 May 2017 - 03 June 2017, http://dx.doi.org/10.1249/01.mss.0000517274.66389.d8

Chan H; Roncolato F; Long A; Foroudi F; Goldstein D; Siva S; Davis I, 2016, 'CURRENT CLINICIAN PRACTICES IN UTILIZING RADIOTHERAPY AND MOLECULARLY TARGETED THERAPIES IN TREATING PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: AN ANZUP SURVEY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 46 - 46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000380004900064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Apte M; Xu Z; Pothula S; Goldstein D; Pirola R; Wilson JS, 2016, 'Stromal remodeling in pancreatic cancer', in Pancreatology, Elsevier, Sendai, pp. S28 - S28, presented at International Association of Pancreatology, Sendai, -

Brungs D; Aghmesheh M; Sjoquist K; Goldstein D, 2015, 'SECOND-LINE CHEMOTHERAPY IN ADVANCED BILIARY TRACT CANCER: A RETROSPECTIVE SERIES', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, pp. 168 - 168, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364320800296&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wang X; Yeo RX; Crowe P; Goldstein D; Hogg P; Dilda P; Yang JL, 2015, 'Synergistic effect of targeting EGFR and metabolism in sarcoma cell lines', Brisbane, Australia, presented at 2015 Annual Sarcoma Conference, Brisbane, Australia, 17 October 2015 - 18 October 2015

Brungs D; Aghmesheh M; Sjoquist K; Goldstein D, 2015, 'FIRST-LINE CHEMOTHERAPY IN ADVANCED BILIARY TRACT CANCER: AN AUSTRALIAN EXPERIENCE', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 51 - 51, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000357957300020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Butow P; Sze M; Goldstein D; Jefford M, 2015, 'Having cancer in a country not your own: the Chinese immigrant story in Australia', in PSYCHO-ONCOLOGY, WILEY-BLACKWELL, pp. 20 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358255000039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Segelov E, 2015, 'TOPS - a randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue', Chicago, presented at 2015 ASCO Annual Meeting, Chicago, 29 May 2015 - 02 June 2015

Price T; Pavlakis N; Karapetis C; Michael M; Singhal N; Goldstein D; Van Hazel G; Zalcberg J; Hicks R; Yeend S; Chua YJ, 2015, 'The Clinical Oncology Society of Australia (COSA) SIGNETURe Neuroendocrine Tumor (NET) Registry of Australia: First Report of Patient Characteristics and Patterns of Care', in NEUROENDOCRINOLOGY, KARGER, SPAIN, Barcelona, pp. 98 - 98, presented at 12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, SPAIN, Barcelona, 11 March 2015 - 13 March 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000361683500062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pothula S; Xu Z; Goldstein D; Pirola R; Wilson JS; Apte M, 2015, 'Pancreatic cancer: stromal reprogramming offers a novel therapeutic approach', San Diego, Pancreas 44(8):1407, presented at American Pancreatic Association, San Diego, Pancreas 44(8):1407, -

Pothula S; Xu Z; Goldstein D; Pirola R; Wilson JS; Apte M, 2015, 'Pancreatic cancer: stromal reprogramming offers a novel therapeutic approach', Shanghai, Pancreatology, presented at International Association of Pancreatology, Shanghai, Pancreatology, -

Pothula S; Xu Z; Goldstein D; Pirola R; Wilson JS; Apte M, 2015, 'Pancreatic cancer: stromal reprogramming offers a novel therapeutic approach', Toledo, Pancreatology 15(3):S17, presented at European Pancreatic Club, Toledo, Pancreatology 15(3):S17, -

Baylock B; Dhillon HM; Goddard EM; Turner J; Rice H; Kabourakis M; Beale P; Ackland S; Seide J; Horvath L; Spencer L; Begbie S; Coppin R; Burge M; Hanley A; Marx G; Canavan R; Ferguson T; Campbell L; Karapetis C; Nolan L; Ashgari R; Liakos R; Iddawela M; Tenance C; Della-Fiorentina S; VanDerMeer R; Price T; Atkinson M; Weng N; Saliba C; Chantrill L; Skinner L; Goldstein D; Tsar C; Walpole E; Moore M; Greenfield K; George M; Hill L; Vardy JL, 2014, 'THE COLON HEALTH AND LIFE-LONG EXERCISE CHANGE (CHALLENGE) TRIAL: PARTICIPANT ADHERENCE TO FITNESS ASSESSMENTS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 200 - 200, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345350900370&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Teo J; Boyer C; Sharbeen G; Sagnella S; Liu J; Youkhana J; Duong HT; Goldstein D; Davis TP; Kavallaris M; McCarroll J; Phillips PA, 2014, 'Design and Synthesis of Novel PEGylated Star Nanoparticles as Delivery Agents for Short-Interfering RNA (siRNA) to Pancreatic Cancer Cells', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1416 - 1416, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344362600356&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Youkhana J; Mccarroll J; Sharbeen G; Erkan M; Liu J; Goldstein D; Phillips PA, 2014, 'Heat shock protein 47 is a potential therapeutic target for the depletion of cancer-promoting stromal cells in pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 7 - 7, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shannon J; Goldstein D; Wong N; Chichen S; Sjoquist K; O'Connell R; Grimison P; McLachlan S; Tebbutt NC; Lipton L; Vasey P; Cronk M; Varma SC; Jefford M; Segelov E; Abdi E; Ng S; Karapetis C; Gebski V; Zalcberg J, 2014, 'A MULTI-CENTRE, PHASE II, OPEN-LABEL, SINGLE ARM STUDY OF PANITUMUMAB, CISPLATIN AND GEMCITABINE IN BILIARY TRACT CANCER: PRIMARY RESULTS OF THE AGITG TACTIC STUDY', in Annals of Oncology, Oxford University Press (OUP), Madrid, Spain, pp. 1 - 1, presented at 39th ESMO Congress (ESMO 2014), Madrid, Spain, 26 September 2014 - 30 September 2014, http://dx.doi.org/10.1093/annonc/mdu334.106

Webber K; Bennett BK; Goldstein D; Lloyd AR, 2014, 'Genetic associations of fatigue and other symptom domains after breast cancer treatment: Results from a prospective cohort study.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 30 May 2014 - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.9537

Yip S; Pavlakis N; Harvie R; Martin A; Jovanovic L; Hudson A; Thompson JF; Nelson C; Long A; Steer C; Harrison ML; Kannourakis G; Goldstein D; Kichenadasse G; Lowenthal RM; Stockler MR; Davis ID, 2014, 'Circulating biomarkers and outcomes in a single-arm phase II trial of first-line sunitinib alternating with everolimus for advanced renal cell carcinoma (aRCC): EVERSUN ANZUP trial 0901', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Genitourinary Cancers Symposium, CA, San Francisco, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.428

Davis ID; Long A; Martin A; Espinoza D; Yip S; Kichenadasse G; Thompson JF; Harrison ML; Lowenthal RM; Pavlakis N; Azad A; Kannourakis G; Steer C; Goldstein D; Shapiro JD; Stockler MR, 2014, 'EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (aRCC) (ANZUP trial 0901)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Genitourinary Cancers Symposium, CA, San Francisco, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.438

Chua YJ; Karapetis CS; Gebski V; O'Connell R; Begbie S; Nott LM; Cronk MF; Underhill C; Abdi EA; Van Hagen T; Wong N; Hall M; Ferraro DA; Sjoquist KM; Santos C; Mackey JR; Goldstein D, 2014, 'Human equilibrative nucleoside transporter 1 (hENT1) in gemcitabine and FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin)-treated patients with metastatic pancreatic cancer: The randomized phase II PAN1 study.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Gastrointestinal Cancers Symposium, CA, San Francisco, 16 January 2014 - 18 January 2014, http://dx.doi.org/10.1200/jco.2014.32.3_suppl.228

Long A; Roncolato F; Foroudi F; Goldstein D; Davis I; Siva S, 2014, 'CURRENT CLINICIAN PRACTICES IN UTILISING RADIOTHERAPY AND TARGETED THERAPIES IN TREATING PATIENTS WITH METASTATIC RENAL CELL CARCINOMA - A SURVEY OF AUSTRALIAN AND NEW ZEALAND CLINICIANS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 36 - 37, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339716200043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wong W; Haghighi KS; Goldstein D, 2014, 'Stereotactic body radiotherapy using 4D image-guidance for inoperable primary liver cancer or metastases', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, pp. S124 - S125, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687118700358&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pothula S; Xu Z; Goldstein D; Pirola R; Wilson JS; Apte M, 2014, 'Hepatocyte Growth Factor (HGF) inhibition may be a superior therapeutic approach than gemcitabine in pancreatic cancer', Melbourne, presented at Australasian Pancreatic Club and the Australian Health and Medical Research Congress, Melbourne, -

Pothula S; Patel M; Xu Z; Lee A; Goldstein D; Pirola R; Apte M; Wilson JS, 2014, 'The role of hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: anti-angiogenic implications in pancreatic cancer', Southampton, Pancreatology 14(3):S9, presented at International Association of Pancreatology and European Pancreatic Club, Southampton, Pancreatology 14(3):S9, -

Sandler C; Webber K; Friedlander M; Lewis C; Chin M; Venkateswaran R; Segelov E; Bastick P; Lynch J; Thomas D; Liauw W; Boyle F; Goldstein D; Lloyd A, 2013, 'BARRIERS TO RECRUITMENT FOR A POST-CANCER FATIGUE INTERVENTION STUDY - THE TOPS TRIAL', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 116 - 116, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sharbeen G; Liu J; McCarroll J; Youkhana J; Teo J; McCarthy N; Goldstein D; Kavallaris M; Phillips PA, 2013, 'beta III-Tubulin is a Novel Therapeutic Target for the Treatment of Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1381 - 1381, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330468400204&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Teo J; Boyer C; Liu J; Sharbeen G; Erlich R; Youkhana J; Duong HT; Goldstein D; Davis TP; Kavallaris M; McCarroll J; Phillips PA, 2013, 'Inhibition of beta III-Tubulin Using a Novel Nanoparticle-siRNA Approach Sensitizes Pancreatic Cancer Cells to Chemotherapy', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1385 - 1385, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330468400222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Scott A; Goldstein D; Grennan K, 2013, 'IS SECOND LINE CHEMOTHERAPY IN PANCREATIC CANCER ONE LINE TOO MANY?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 150 - 150, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800282&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Beesley VL; Janda M; Wockner LF; O'Rourke P; Gooden H; Goldstein D; Merrett ND; Wyld DK; Neale RE, 2013, 'PANCREATIC CANCER PATIENT'S MODERATE OR HIGH UNMET SUPPORTIVE CARE NEEDS OVER TIME AND RISK FACTORS OF FUTURE UNMET NEEDS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 105 - 105, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Goldstein D, 2013, 'Therapeutic Potential of Angiogenesis Inhibitors for Gastric Cancer', in Annals of Oncology, pp. ix8, http://dx.doi.org/10.1093/annonc/mdt437.1

Pothula S; Xu Z; Arun S; Goldstein D; Biankin A; Pirola R; Wilson J; Apte M, 2013, 'Hepatocyte Growth Factor Inhibition: A Therapeutic Approach Superior to Gemcitabine in Pancreatic Cancer?', in Pancreas, Lippincott Williams & Wilkins, Miami, pp. 1377 - 1377, presented at American Pancreatic Association, Miami, 31 October 2013 - 02 November 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000330468400188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sharbeen G; Liu J; Mccarroll J; Youkhana J; Teo J; Mccarthy N; Goldstein D; Kavallaris M; Phillips PA, 2013, 'beta III-tubulin is a novel therapeutic target for the treatment of pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 12 - 12, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Scheithauer W; Von Hoff DD; Ramanathan RK; Moore M; Tabernero J; Goldstein D; Hammel P; Kunzmann V; Ko A; Romano A, 2013, 'Dose delivery in a phase III trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) vs G alone for patients with metastatic adenocarcinoma of the pancreas', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S614 - S614, presented at European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, NETHERLANDS, Amsterdam, 27 September 2013 - 01 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326843604024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Goldstein D; Von Hoff DD; Moore M; Greeno E; Ritch P; Tortora G; Ramanathan RK; Tabernero J; Ko A; Lu B, 2013, 'Evaluation of peripheral neuropathy in a phase Ill trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) vs G alone for patients with metastatic adenocarcinoma of the pancreas', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S613 - S613, presented at European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, NETHERLANDS, Amsterdam, 27 September 2013 - 01 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326843604021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ramanathan RK; Von Hoff DD; Moore M; Teixeira L; Siena S; Tabernero J; Goldstein D; Wei X; Lu B, 2013, 'Positron emission tomography (PET) response from a randomized phase III trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) vs G alone for patients (pts) with metastatic adenocarcinoma of the pancreas', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S611 - S611, presented at European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, NETHERLANDS, Amsterdam, 27 September 2013 - 01 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326843604015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bennett B; Webber K; Goldstein D; Lloyd A, 2013, 'What do patients really mean when they complain of fatigue after treatment? Reliable identification of post cancer fatigue', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S283 - S283, presented at European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, NETHERLANDS, Amsterdam, 27 September 2013 - 01 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326843602060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chiorean EG; Von Hoff DD; Ervin TJ; Arena FP; Infante JR; Bathini VG; Wood TE; Mainwaring PN; Muldoon RT; Clingan PR; Kunzmann V; Ramanathan RK; Tabernero J; Goldstein D; Ko A; Lu B, 2013, 'CA19-9 decrease at 8 weeks as a predictor of overall survival (OS) in a randomized phase III trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone in patients with metastatic pancreatic cancer (MPC).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419601432&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hammel P; Huguet F; Van Laethem J-L; Goldstein D; Glimelius B; Artru P; Borbath I; Bouche O; Shannon J; Andre T; Mineur L; Chibaudel B; Bonnetain F; Louvet C, 2013, 'Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419605339&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pavlakis N; Goldstein D; Sjoquist KM; Martin A; Tsobanis E; Yip S; Shannon J; Burge ME; Cronk MF; Tebbutt NC; Strickland A; Lipton LR; Price TJ; Nott LM; Harris DL; Burnell MJ; Alcindor T; Bang Y-J; Kang Y-K; O'Callaghan CJ, 2013, 'INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced esophagogastric cancer (AOGC)-A study by the Australasian Gastrointestinal Trials Group (AGITG)', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419605441&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Moore MJ; Von Hoff DD; Ervin TJ; Arena FP; Chiorean EG; Infante JR; Hon JK; Biakhov MY; Hingorani SR; Ganju V; Weekes CD; Scheithauer W; Ramanathan RK; Tabernero J; Goldstein D; Wei X; Romano A, 2013, 'Prognostic factors (PFs) of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone in patients (pts) with metastatic pancreatic cancer (MPC).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419601433&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Von Hoff DD; Ervin TJ; Arena FP; Chiorean EG; Infante JR; Moore MJ; Seay TE; Tjulandin S; Ma WW; Saleh MN; Harris M; Reni M; Ramanathan RK; Tabernero J; Hidalgo M; Van Cutsem E; Goldstein D; Wei X; Iglesias JL; Renschler MF, 2013, 'Results of a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas with PET and CA19-9 correlates', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419601380&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Butow PN; Sze M; Eisenbruch M; Bell M; Aldridge L; Vardy JL; Hui R; Boyle F; Liauw WS; Goldstein D, 2013, 'Should culture affect practice? Prognostic discussions with immigrants', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419602272&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vickers MM; Tu D; Lee C; Wheatley-Price P; Parulekar W; Brundage MD; Moore MJ; Au H-J; O'Callaghan CJ; Jonker DJ; Ringash J; Goldstein D, 2013, 'Significance of baseline quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419601427&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hammel P; Huguet F; Van Laethem J-L; Goldstein D; Glimelius B; Artru P; Borbath I; Bouche O; Shannon J; Andre T; Mineur L; Chibaudel B; Bonnetain F; Louvet C, 2013, 'Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335564000024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Goddard EM; Dhillon HM; Turner J; Kabourakis M; Beale PJ; Goodwin A; Goldstein D; Clarke SJ; Ouriques M; Ackland SP; Abell F; Bonaventura A; Mallesara G; Fischer C; Kreiger L; Lashbrook M; Vardy JL, 2012, 'THE IMPACT OF PHYSICAL ACTIVITY ON DISEASE-FREE SURVIVAL IN PATIENTS WITH HIGH-RISK STAGE II OR III COLON CANCER: ONE MONTH SCREENING RESULTS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 345 - 345, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310544400386&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Racadot S; Hammel P; Chibaudel B; Goldstein D; Spry N; Van Laethem J; Van Houtte P; Glimelius B; Gubanski M; Huguet F, 2012, 'Dummy Run in the Phase III LAP07 Pancreatic Cancer Trial: First Evaluation of Quality of Radiation Therapy Planning', in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ELSEVIER SCIENCE INC, MA, Boston, pp. S322 - S322, presented at 54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), MA, Boston, 28 October 2012 - 31 October 2012, http://dx.doi.org/10.1016/j.ijrobp.2012.07.845

Fawcett J; Sjoquist KM; Padbury R; Christophi C; Tebbutt NC; Pilgrim CHC; Gebski V; Wong N; Aiken C; Goldstein D, 2012, 'ATTACHE: A phase III, multicenter, randomized comparison of chemotherapy given prior to and post surgical resection versus chemotherapy given post surgical resection for hepatic metastases from colorectal cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 01 June 2012 - 06 June 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009803692&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Butow PN; Aldridge L; Bell M; Sze M; Eisenbruch M; King M; Jefford M; Schofield P; Duggal-Beri P; Goldstein D, 2012, 'Cancer survivorship outcomes in immigrants.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 01 June 2012 - 06 June 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009801015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page